Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy. | Int J Mol Sci | 2024 | 38396765 | PubTator, text mining | PubMed |
| PRFect: a tool to predict programmed ribosomal frameshifts in prokaryotic and viral genomes. | BMC Bioinformatics | 2024 | 38389044 | PubTator, text mining | PubMed |
| Diversity and evolution of the vertebrate chemoreceptor gene repertoire. | Nat Commun | 2024 | 38360851 | PubTator, text mining | PubMed |
| Pharmacokinetics, pharmacodynamics and safety of 15 mg-tolvaptan administered orally for 7 consecutive days to Chinese patients with child-Pugh B cirrhosis. | Front Pharmacol | 2024 | 38344178 | PubTator, text mining | PubMed |
| Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus. | Int J Mol Sci | 2024 | 38279313 | PubTator, text mining | PubMed |
| Charge manipulation of the human insulin B chain C-terminal to shed light on the complex mechanism of insulin fibrillation. | Biochim Biophys Acta Gen Subj | 2024 | 38278307 | PubTator, text mining | PubMed |
| The Pathophysiology of Inherited Renal Cystic Diseases. | Genes (Basel) | 2024 | 38254980 | PubTator, text mining | PubMed |
| Targeted long-read sequencing identified a causal structural variant in X-linked nephrogenic diabetes insipidus. | BMC Med Genomics | 2024 | 38254165 | PubTator, text mining | PubMed |
| Liver sinusoidal endothelial cells as potential drivers of liver fibrosis (Review). | Mol Med Rep | 2024 | 38240102 | PubTator, text mining | PubMed |
| Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain. | Acta Pharm Sin B | 2024 | 38239234 | PubTator, text mining | PubMed |
| DKK3 as a potential novel biomarker in patients with autosomal polycystic kidney disease. | Clin Kidney J | 2024 | 38186869 | PubTator, text mining | PubMed |
| Molecular insights into atypical modes of β-arrestin interaction with seven transmembrane receptors. | Science | 2024 | 38175886 | PubTator, text mining | PubMed |
| Extended Metadynamics Protocol for Binding/Unbinding Free Energies of Peptide Ligands to Class A G-Protein-Coupled Receptors. | J Chem Inf Model | 2024 | 38150388 | PubTator, text mining | PubMed |
| The First Case of Congenital Nephrogenic Diabetes Insipidus Caused by AVPR2 Disruption Because of 4q25 Insertional Translocation. | Ann Lab Med | 2024 | 38145893 | PubTator, text mining | PubMed |
| Nonlinear and Emissive {[MIII(CN)6]3-···Polyresorcinol} (M = Fe, Co, Cr) Cocrystals Exhibiting an Ultralow Frequency Raman Response. | Inorg Chem | 2024 | 38109502 | PubTator, text mining | PubMed |
| Biochemical characterization of the Drosophila insulin receptor kinase and longevity-associated mutants. | FASEB J | 2024 | 38071609 | PubTator, text mining | PubMed |
| From membrane to nucleus: A three-wave hypothesis of cAMP signaling. | J Biol Chem | 2024 | 38016514 | PubTator, text mining | PubMed |
| Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD. | Nephrol Dial Transplant | 2024 | 37935473 | PubTator, text mining | PubMed |
| Vasopressin V2 receptor, tolvaptan, and ERK1/2 phosphorylation in the renal collecting duct. | Am J Physiol Renal Physiol | 2024 | 37916285 | PubTator, text mining | PubMed |
The pharmacological actions of Danzhi-xiaoyao-San on depression involve lysophosphatidic acid and microbiota-gut-brain axis: novel insights from a systems pharmacology analysis of a double-blind, randomized, placebo-controlled clinical trial. | J Biomol Struct Dyn | 2024 | 37632305 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=9